0 likes | 3 Vues
The Leuprolide Acetate Market was valued at USD 2.8 billion in 2024 and is anticipated to reach around USD 4.9 billion by 2034, exhibiting a compound annual growth rate (CAGR) of 6% over the 2025u20132034 forecast period. Market growth is driven by the increasing prevalence of hormone-dependent conditions such as prostate cancer, endometriosis, and uterine fibroids, along with rising awareness and adoption of advanced hormonal therapies globally.
E N D